Cite
HARVARD Citation
Bili, A. et al. (n.d.). 1184. A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of V114 and Prevnar 13™ with Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRECTION). Open forum infectious diseases. p. S684. [Online].